PINK1 and gastric adenocarcinoma: Recent studies underscore how defects in mitochondrial quality control, such as PINK1 insufficiency, can sensitize gastric adenocarcinoma cells to therapies targeting mitochondrial dynamics, linking mitochondrial distress to impaired immune responses (51).